Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries
Open Access
- 17 May 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Abstract
Reported incidence of pertussis in the European Union (EU) and the European Economic Area (EEA) varies and may not reflect the real situation, while vaccine-induced protection against diphtheria and tetanus seems sufficient. We aimed to determine the seroprevalence of DTP antibodies in EU/EEA countries within the age groups of 40–49 and 50–59 years. Eighteen countries collected around 500 samples between 2015 and 2018 (N = 10,302) which were analysed for IgG-DTP specific antibodies. The proportion of sera with pertussis toxin antibody levels ≥100 IU/mL, indicative of recent exposure to pertussis was comparable for 13/18 countries, ranging between 2.7–5.8%. For diphtheria the proportion of sera lacking the protective level (B. pertussis across EU/EEA while the lack of vaccine-induced seroprotection against diphtheria is of concern and deserves further attention.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Increased Population Prevalence of Low Pertussis Toxin Antibody Levels in Young Children Preceding a Record Pertussis Epidemic in AustraliaPLOS ONE, 2012
- Improved Specificity of a Multiplex Immunoassay for Quantitation of Anti-Diphtheria Toxin Antibodies with the Use of Diphtheria ToxoidClinical and Vaccine Immunology, 2011
- Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussisPLOS ONE, 2010
- Contact Network Structure Explains the Changing Epidemiology of PertussisScience, 2010
- What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratoriesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccineJournal of Medical Microbiology, 2010
- Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European CountriesPLOS Medicine, 2010
- Seroprevalence of pertussis antitoxin (anti‐PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination programAPMIS, 2009
- The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveysJournal of Infection, 2006
- The seroepidemiology of pertussis in Australia during an epidemic periodEpidemiology and Infection, 2006